Irwin Naturals Announces Intention to File Draft Registration Statement

March 1, 2022
News

VANCOUVER, British Columbia, March 01, 2022 (GLOBE NEWSWIRE) -- CNW / – Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”), has announced its intent to submit a draft registration statement on Form S-1 to the U.S. Securities and Exchange Commission, relating to a proposed primary, initial public offering (“IPO”) of its common shares in the United States. The number of common shares to be offered, the use of proceeds, and the price range for the proposed IPO have not yet been determined. The IPO is subject to market and other conditions, including the effectiveness of the Registration Statement.

This news release does not constitute an offer to sell or the solicitation of an offer to buy any securities. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended ("Securities Act"). This announcement is being issued in accordance with Rule 135 under the Securities Act.

To contact Klee Irwin, Chief Executive Officer, or the company you can send an e-mail to Investors@IrwinNaturals.com.

Always do your own research and make your own investment decisions. This is not a solicitation to purchase or sell securities. Psychedelic Finance is not a registered investment advisor and does not purport to provide investment advice, whether implied or otherwise. Psychedelic Finance does not independently verify the accuracy or the truth of the statements or representations made by issuers. This message is meant for information and educational purposes only and Psychedelic Finance does not intend for this information to be used to inform an investment decision.